FindTrial
Sign In

The effect on dose-response of adding magnesium to intrathecal bupivacaine for spinal anesthesia in cesarean section

The effect on dose-response of adding magnesium to intrathecal bupivacaine for spinal anesthesia in cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004954
Enrollment
Unknown
Registered
2014-07-15
Start date
2014-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section

Interventions

1:Magnesium sulfate + bupivacaine
2:bupivacaine

Sponsors

Zhejiang University Medical Collage, Women's Hospital Medical
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 30 Years

Inclusion criteria

Inclusion criteria: single birth, mature (37w-40w), primiparty, ASA I-III

Exclusion criteria

Exclusion criteria: Spinal canal contraindications, fetal distress, maternal medical complications.

Design outcomes

Primary

MeasureTime frame
THE ED50 OF BUPIVACAINE;the onset of sensory block;the duration of sensory block;the recovery of sensory block;the onset of motor block;the duration of motor block;the recovery of motor block;duration of spinal anaesthesia;VAS SCOR;—

Secondary

MeasureTime frame
the requiement of postoperative analgesia;—

Countries

China

Contacts

Public ContactFei Xiao, Xinzhong, Chen
1036230359@qq.com+86 13706597501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 11, 2026